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Abstract
Background: Electronic formats of patient-reported outcome (PRO) measures are now routinely used in clinical
research studies. When changing from a validated paper and pen to electronic administration it is necessary to
establish their equivalence. This study reports on the value of Rasch analysis in this process.
Methods: Three groups of US pulmonary hypertension (PH) patients participated. The first completed an electronic
version of the CAMPHOR Activity Limitation scale (e-sample) and this was compared with two pen and paper
administrated samples (pp1 and pp2). The three databases were combined and analysed for fit to the Rasch model.
Equivalence was evaluated by differential item functioning (DIF) analyses.
Results: The three datasets were matched randomly in terms of sample size (n = 147). Mean age (years) and
percentage of male respondents were as follows: e-sample (51.7, 16.0 %); pp1 (50.0, 14.0 %); pp2 (55.5, 40.4 %). The
combined dataset achieved fit to the Rasch model. Two items showed evidence of borderline DIF. Further analyses
showed the inclusion of these items had little impact on Rasch estimates indicating the DIF identified was unimportant.
Conclusions: Differences between the performance of the electronic and pen and paper administrations of the
CAMPHOR Activity Limitation scale were minor. The results were successful in showing how the Rasch model can be
used to determine the equivalence of alternative formats of PRO measures.
Keywords: Patient reported outcome (PRO) measures, Cambridge Pulmonary Hypertension Outcome Review
(CAMPHOR), Item response theory (IRT), Rasch analysis, Electronic validation, Measurement equivalence
Background
Patient reported outcomes (PROs) provide a crucial
means of assessing the impact of a condition and its
treatment from the patients’ perspective. It has become
increasingly common for PROs to be used as secondary
(and even primary) endpoints in clinical trials [1]. In
such studies electronic formats are generally employed.
These may offer a range of benefits such as improving
access to patients, increasing compliance, reducing miss-
ing data and avoiding errors associated with manual data
entry [2–4]. Adapting pen and paper measures for use
electronically requires a number of format changes.
These may include changes to item presentation, in-
structions and/or response format. Various electronic
devices are used including personal computers, tablets,
cell phones and handheld devices. Smaller devices often
entail major formatting changes as they require the PRO
to be broken into small sections to fit the screen. The
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way in which participants are required to respond on
these devices can differ; for example, by using a standard
mouse or a touch screen monitor. An important ques-
tion is whether or not changes in format affect data gen-
erated from the measure. In order to investigate this it is
necessary for the new format to undergo formal equiva-
lence testing.
A recent literature review showed that several studies
have attempted to assess equivalence between different
formats of PROs [5]. However, the way in which equiva-
lence is tested varies from study to study. These methods
usually involve comparing sample means and/or assessing
the level of agreement between the different formats using
correlational techniques. Such studies have design limita-
tions and only assess a small aspect of true ‘measurement
equivalence’. For example, the statistic most widely used
for assessing association is the intraclass correlation
coefficient (ICC). However, the ICC requires interval/
ratio level data, making its use inappropriate with most
PROs currently available that produce data at the or-
dinal level [6].
Studies of association usually use a cross-over design
in which participants are randomized to complete either
a paper and pen version or an electronic version of the
same PRO and then the other mode on a second admin-
istration. Generally, the time between administrations is
short, with patients completing both formats at the same
visit [7–9]. This is likely to lead to recall bias and in-
flated levels of agreement.
An alternative design employed is a parallel groups de-
sign in which participants are randomized to complete
either a paper and pen version or an electronic version
of the PRO. Mean scores on the measures are then com-
pared and differences in these either considered in rela-
tion to minimal important difference values (if available)
or effect sizes. Unfortunately, this approach gives mark-
edly less information about measurement equivalence
and is liable to bias if the samples are not closely matched
on clinical characteristics.
A guidance document produced by the International
Society for Pharmacoeconomics and Outcomes Research
ePRO Good Research Practices Task Force [10] provides
recommendations on the steps necessary to establish
equivalence. The document suggests that respondent us-
ability should always be assessed and that measurement
equivalence should be tested quantitatively when ‘mod-
erate’ changes are made to the format. The document
follows common practice by recommending use of one
of the two designs described above.
One of the major advances in PRO development and
application in recent years has been the adoption of Item
Response Theory (IRT) and, in particular, Rasch analysis
[11]. Unlike Classical Test Theory (CTT), IRT gives
greater emphasis to item-level rather than test-level
information and provides superior detail on the meas-
urement properties of scales [12–14]. Although IRT has
been identified as a potentially useful method for
evaluating measurement equivalence [10] a review of
the literature identified just two studies applying this
approach [15, 16].
The Rasch model allows a series of detailed properties
to be evaluated that can be applied to the assessment of
measurement equivalence. These include individual item
fit statistics, overall fit statistics, item severity ordering
and the functioning of response options. In addition, it
allows measurement bias at the item level to be assessed
using differential item functioning (DIF). This is of par-
ticular relevance to measurement equivalence as DIF by
mode of administration (paper and pen versus electronic)
can be tested.
The aim of the present study was to compare the
measurement equivalence of pen and paper and elec-
tronic formats of the Activity Limitation scale of the
Cambridge Pulmonary Hypertension Outcome Review
(CAMPHOR) [17] using Rasch analysis.
Methods
CAMPHOR Activity Limitation
The CAMPHOR Activity Limitation scale employs the
World Health Organization’s Classification of Function-
ing, Disability and Health [18] and consists of 15 items
with three response options (Able to do on own without
difficulty/Able to do on own with difficulty/Unable to do
on own). Rasch analysis was used in the development of
this scale to ensure unidimensionality and good meas-
urement properties.
An electronic version of the scale was designed to re-
semble the original paper and pen version as closely as
possible. The items were presented on whole pages in
the same way as the original. A minor change to the re-
sponse format was made with participants asked to
‘click’ the relevant response option using the cursor. In
addition, the instructions were changed with patients
asked to ‘click’ their response rather than to ‘check a
box’. All other instructions were identical to the paper
and pen version.
Samples
Three separate samples of PH patients were included in
the study. One sample completed an electronic version
of the CAMPHOR and the other samples filled in a
paper and pen version. All samples consisted of US pa-
tients with PH. Subscribers to listservs of the Pulmonary
Hypertension Association, recruited by the Mayo Clinic,
Rochester, completed an electronic version of the
CAMPHOR (e-sample) [19]. A second sample, drawn
from the Adelphi Real World Pulmonary Arterial Hyper-
tension Disease Specific Programme [20], completed the
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paper and pen CAMPHOR at outpatient clinics and spe-
cialist PH centres (pp1-sample). The second paper and
pen sample (pp2-sample) was recruited by the University
of Chicago from a tertiary referral centre [21]. The ori-
ginal e-sample and pp1 samples consisted of 276 and
151 participants respectively. Random samples (gener-
ated via SPSS 19 random sample selection generator) of
147 patients were chosen from each of these clinical
samples to match the size of the pp2 sample.
For the e-sample, ethics approval was provided by the
Mayo Clinic Institutional Review Board. The pp-1 sam-
ple dataset was collected through a market research sur-
vey and accordingly ethics approval was not sought. For
the pp-2 sample, ethics approval was provided by the
University of Chicago Institutional Review Board. In-
formed consent was given by participants in all studies.
The samples were not matched for disease severity
and the CAMPHOR was administered in different loca-
tions (clinic or home).
Design
Data generated from the three samples of PH patients
were compared. The design allowed any lack of equiva-
lence between the functioning of electronic and pen and
paper formats to be considered in the context of two dif-
ferent pen and paper administrations.
Figure 1 provides a flow chart detailing the design of
the study. The three datasets were combined for the
analyses. Three stages were involved:
1. Assessment of fit to the Rasch model: In order to
assess equivalence, it was first necessary to
re-establish that the combined scales were
unidimensional with good fit to the Rasch model.
Therefore, the analyses assessed the PRO scales’
standard fit statistics [22]. If fit statistics are adequate
it is possible to assess measurement equivalence.
2. Measurement equivalence was assessed by
investigating DIF [23] by method of administration.
DIF occurs when sub-groups of a sample respond in
different ways to a particular item, despite having
the same level of the underlying trait being mea-
sured. This provides a way of assessing whether dif-
ferent formats of a measure produce bias at the item
level. If there is no evidence of DIF then the measure
exhibits equivalence. If DIF is shown it is necessary
to assess its importance. If it is non-significant then
equivalence is assumed.
The analyses are described in detail below.
1. Fit to the Rasch model
The Rasch model
The Rasch model is a simple logistic latent trait IRT
model [11]. Based on a probabilistic form of
Guttman scaling, it states that items and persons
can be located on the same linear scale. The
probability of a given respondent affirming an item
is defined as the relative distance between the item
location (difficulty) and the respondent location
(ability) on that scale. In relation to health outcome,
it is a logistic function of the difference between a
person’s severity level and the severity level of the
item. In order to assess the measurement properties
of a questionnaire formally, the response pattern
created by the items is compared to that expected
Fig. 1 Design of the study
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by the Rasch model. If the observed data do not
deviate significantly from the expected responses the
items fit the Rasch model.
The Rasch Unidimensional Measurement Model
(RUMM) 2030 [24] program was employed.
Before analyses were conducted it was necessary to
determine whether the rating scale [25] or partial
credit model [26] was most appropriate. Both of
these approaches use the Rasch model but differ
slightly in their mathematics. The rating scale model
is more stringent in its requirements as the distance
between response thresholds has to be uniform
across all items. The likelihood ratio test is used to
identify the most appropriate model.
Overall fit to the Rasch model
Fit to the Rasch model was examined by looking at
the overall item-trait interaction Chi2 fit value. A
non-significant Chi2 statistic (p > 0.05) indicates that
the scale fits the Rasch model. Bonferroni corrections
were applied to the statistical p-values throughout the
analyses due to the large number of tests conducted
(Bonferroni adjusted p value > 0.003).
Individual item fit
Individual item fit statistics were also used to
investigate overall fit to the Rasch model. A
significant Chi2 fit statistic (p < 0.05 (Bonferroni
adjusted)) indicates misfit to the model. Fit residuals
also provide a valuable source of information. These
should fall within ±2.5. High negative residuals
suggest that an item may be redundant, whereas
high positive residuals suggest multi-dimensionality.
In both cases they are indicative of misfit. Person fit
residual and item fit residual statistics are transformed
by RUMM to approximate z-scores. These z-scores,
the residual mean values of person and item fit, can
also be used to assess overall fit to the Rasch model.
Perfect fit is represented by a mean anchored at 0 and
a standard deviation of 1.
Internal Reliability – Person Separation Index (PSI)
The Person Separation Index (PSI) was employed to
analyse internal reliability. This indicates the power
of the items to distinguish between respondents. A
PSI score of 0.8 is considered the minimum
acceptable level.
Functioning of response options
Response thresholds are investigated to determine
the adequacy of the response format. Thresholds
represent locations on the latent continuum at
which it will be equally likely that adjacent response
options will be selected. Thresholds should be
logically ordered. If response options are disordered
they do not work as intended. This is an important
area for the present study as the method of
responding could influence the thresholds.
Unidimensionality
As noted above, evidence of unidimensionality is
first investigated by looking at the item fit residuals.
Evidence of unidimensionality was also investigated
using t-tests to compare estimates derived from two
separate subsets of items (loading most differently
on the first factor of the Residual Principal
Component Analysis) [27]. If a scale is
unidimensional these two subsets of items should
give the same estimate of person ability. Generally, if
more than 5 % of these t-tests are statistically
significantly different, it is indicative of a
multidimensional scale. A 95 % binomial confidence
interval (using a normal approximation) is provided
to indicate the interval within which the true value
lies in repeated testing.
2. Assessment of equivalence
DIF was employed to test for equivalence between
the different formats of the Activity Limitation scale.
Analyses of variance (ANOVA) were employed to
identify DIF by administration mode (e-sample
versus pp1 versus pp2). Significant p-values (p < 0.05)
indicate the presence of DIF.
3. Assessing the impact of DIF
If DIF is identified it is necessary to assess the extent
to which it influences the calculation of the Rasch
estimates. If DIF is minor, its influence on estimates
may be only slight. The importance of any identified
DIF was tested using a method outlined by Tenant
and Pallant [28]. Rasch estimates are first calculated
using a ‘pure’ dataset where items exhibiting DIF are
removed. These estimates are then saved to an
anchor file. The whole dataset, including items
exhibiting DIF, are anchored to this dataset so that
the estimates are defined by the measurement
framework of the ‘pure’ items. The resulting
estimates (pure vs. full anchored dataset) are then
compared. The proportion of estimates that differ by
0.5 logits is calculated to assess for the proportion of
non-trivial DIF. Distribution of the estimates
(including mean, standard deviation, median and
interquartile range), correlation (intraclass correlation
coefficient) between estimates and differences between
the estimates (t-test) were also calculated.
Results
Demographic information for the three samples is shown
in Table 1. World Health Organization functional (WHO)
classification and Six Minute Walk Test (6MWT) scores
at time of administration of the CAMPHOR were only
available for the two paper and pen samples. The pp1
sample had a longer duration of PH while the pp2 sample
included a higher proportion of males. The WHO classifi-
cations suggested that the pp1 sample had greater disease
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severity which was supported by the CAMPHOR Activity
Limitation raw scores. The e-sample had comparable Ac-
tivity Limitation scores to the pp1 sample.
Further investigation was conducted using DIF analysis
to assess whether differences in severity could have im-
pacted on the equivalence testing results. There was no
evidence of DIF by WHO classification (pp1 vs. pp2)
after Bonferroni corrections were applied.
Fit to the Rasch model
The initial Likelihood Ratio test, used to determine the
most appropriate Rasch model, was statistically signifi-
cant supporting the use of the partial credit model for
the analyses (p < .001).
Table 2 shows overall fit statistics for the combined
samples. The combined dataset showed fit to the Rasch
model (Chi2 = 0.028). In addition, the person separation
index statistics indicated that the scale showed good reli-
ability. Individual item fit is shown in Table 3. Each of
the 15 items demonstrated fit to the Rasch model after
Bonferroni corrections were applied (Chi2 ˃ 0.05).
Response thresholds for each item (in location order)
are shown in Fig. 2. The results showed that the re-
sponse format worked appropriately for all items. No
disordered response thresholds were identified.
Assessment of equivalence
None of the items showed DIF by administration after
application of Bonferroni corrections. However, one item
(item 5, p = 0.003) showed borderline non-uniform DIF
and another showed borderline uniform DIF (item 12,
p = 0.002). These items were investigated in more detail.
Figure 3 shows uniform DIF by administration for
item 12 (Lift heavy objects). The curved line represents
expected scores by class of people or class of interval for
this item and the points represent the observed scores
for each of the three samples. Members of the pp2 sam-
ple were most likely to affirm the item at each point. A
post-hoc analysis supported this, showing that the pp2
sample differed significantly from the pp1 sample and
the e-sample.
Figure 4 shows non-uniform DIF by administration for
item 5 (Walk short distances on level ground). As this








Male 23 (16) 20 (14) 57 (40.4)
Female 121 (84) 123 (84) 84 (59.6)
Age (years)
Mean (SD) 51.7 (13.9) 50.0 (14.6) 55.5 (12.7)
Range 20.0–82.0 16.0–82.0 21.0–93.0
PH duration (years)
Mean (SD) 4.7 (3.8) 12.1 (4.9) 4.3 (4.0)
Range 0.0–19.0 7.0–29.0 3.0–21.0
6MWT (metres)
Mean (SD) - 385.6 (112.6) 396.7 (170.1)
Range - 155.0–701.0 55.0–862.0
WHO classification (%)
I - 4 (2.9) 132 (95)
II - 58 (42.3) 2 (1.4)
III - 73 (53.3) 4 (2.9)
IV - 2 (1.5) 0 (0)




68 (46.3) 81 (55.1) 67 (45.6)
Associated PH 17 (11.6) 62 (42.2) 65 (44.2)
PH due to left
heart disease
9 (6.1) 0 (0) 2 (1.4)
PH due to
lung conditions
10 (6.8) 0(0) 4 (2.9)
PH due to
other conditions
24 (16.3) (0) 1 (0.7)
Reasons for PH
unknown
19 (12.9) 4 (2.7) 8 (5.4)
CAMPHOR Activity
limitation raw score
Mean (SD) 18.07 (3.99) 17.91 (3.11) 8.04 (6.33)
Median (IQR) 18.0 (15.0–21.0) 18.0 (16.0–20.0) 7.0 (3.0–13.0)
%min 0.7 0.7 17.7
%max 0.7 2.0 0.7
Range 4.0–30.0 6.0–26.0 0.0–26.0
Table 2 Overall fit statistics for the combined dataset
Scale Item-trait interaction PSI Item-person fit residuals Unidimensionality
(95 % Confidence Interval)Chi2 P-value Item fit residual Person fit residual
Mean SD Mean SD
Activity limitation 0.027 0.907 −0.77 0.99 −0.45 1.02 0.064 (0.042–0.085)
Ideal values >0.003a >0.8 0 ± 1 0 ± 1 <0.05
aBonferroni adjusted
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DIF was non-uniform, it was not possible to identify an
administration mode that differed consistently from the
others.
In order to assess the level of bias exhibited by items 5
and 12, Rasch estimates were compared between a pure
dataset excluding these items and an anchored dataset
including them. There were only minor differences be-
tween the two estimates (with DIF items mean (SD) =
−2.17 (2.38), without DIF items mean (SD) = −2.19
(2.41), t-test p = 0.224). Only 3.4 % of person estimates
differed by more than 0.5 logits. In addition, a correl-
ation between the two sets of estimates was very high
(intraclass correlation coefficient = .998). Overall, the re-
sults indicate that the DIF identified was unimportant.
Discussion
The study shows that it is feasible to use the Rasch model
to assess measurement equivalence of the CAMPHOR
Activity Limitation scale. The study has provided a clear
methodological framework for using the Rasch model in
this process. A three-step approach was used where fit to
the Rasch model was first established, measurement
equivalence was assessed using DIF analyses and the im-
portance of the identified DIF investigated.
Adequate fit to the Rasch model was achieved in the
first step. Overall and item level fit statistics showed the
scale had good fit to the Rasch model. Results also
showed support for the functioning of the response for-
mat. Problems with the functioning of the response
options have been identified frequently when Rasch ana-
lysis is applied to existing scales [29–31]. The method of
responding to items differs between modes of adminis-
tration, underlining the importance of assessing response
option functioning. In the present study, the functioning
of the response options was good with no disordered re-
sponse thresholds identified. This is likely to be due to
the response options for the CAMPHOR Activity Limi-
tation scale being carefully designed using Rasch-based
evidence.
Only minor evidence of DIF by type of administration
was found. This was investigated in more detailed using a
systematic approach outlined previously by Tennant and
Pallant [28]. This determined whether the minor DIF
identified had an important influence on estimates gener-
ated from the scale. This step is essential when DIF is
identified in order to assess the degree of bias that items
produce at the test level. The fact that two paper and pen
versions were available allowed the electronic format to be
compared carefully in relation to normal sample to sample
variation. The results suggested that the electronic format
did not differ more than the two paper and pen formats
Table 3 Individual Item Fit
Item Location SE Fit residual Chi2 Prob
Cut toenails 0.25 0.11 0.81 14.61 0.024
Bathe 2.02 0.14 −1.32 5.60 0.470
Get dressed 2.64 0.15 −0.35 7.02 0.319
Walk around house 2.52 0.15 −1.14 5.87 0.437
Walk short level distances 1.82 0.14 −1.43 4.49 0.611
Walk longer level distance −0.37 0.11 −1.87 5.65 0.464
Walk up incline −0.30 0.12 −2.15 10.39 0.109
Climb a flight of stairs −1.18 0.11 −1.89 9.48 0.148
Bend to pick up objects 0.80 0.12 0.12 7.46 0.280
Stand for short time 2.20 0.15 0.51 4.23 0.646
Stand for long time −0.76 0.11 −0.43 4.70 0.583
Lift heavy objects −2.77 0.10 0.43 15.67 0.016
Carry heavy items −3.42 0.11 −0.07 3.95 0.684
Do light house work −0.10 0.11 −2.04 10.30 0.113
Do heavy housework −3.33 0.11 −0.73 8.07 0.233
Fig. 2 Response threshold map
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differed from each other. The results of these analyses
supported the measurement equivalence of electronic and
pen and paper versions of the CAMPHOR scales.
The success of the equivalence testing in this study
should be considered in relation to the extent of changes
in format that were made to the electronic version of
the questionnaire. The new format was designed to re-
semble the original measure as closely as possible, having
the same layout and with only minor necessary changes to
the instructions. More extensive changes could well affect
the Rasch fit statistics.
Two previous studies were identified that have applied
IRT to assess measurement equivalence [15, 16]. One of
these studies applied Rasch analysis [16]. The results of
this latter study were limited to an analysis of DIF by
mode of administration and no formal investigation of
the impact of the DIF on overall scores was performed.
The present study has provided a more detailed ap-
proach to assessing equivalence using Rasch analysis and
provides a foundation for future studies.
The use of Rasch analysis to test equivalence is likely
to increase in the future as it has a number of advan-
tages over CTT approaches. Its use gives considerably
more detailed information on the measurement proper-
ties of scales allowing true ‘measurement’ equivalence to
be determined. Analyses based only on association or
comparisons of means have limited ability to detect lack
of equivalence. The study design is simpler than ran-
domized cross over designs as only one sample for each
format is required. Although two paper and pen versions
were used in the present study, this would not be neces-
sary in standard equivalence testing. There is also no
need to match samples in terms of disease severity or lo-
cation at which they were completed.
A potential limitation of the Rasch approach is that rela-
tively large sample sizes are needed (approximately 150)
for each format. However, similar sample sizes would
provide more accurate estimates when applying CTT ap-
proaches and it is crucial to know whether different for-
mats are equivalent in many situations. A major limitation
of this approach is that relatively few PRO measures fit
the Rasch model due to their age and/or the lack of a co-
herent measurement model. This is actually a weakness of
the PRO measures as in such cases it will remain difficult
to establish the equivalence of different formats of the
measures.
Fig. 3 DIF by administration for item 12 (uniform)
Fig. 4 DIF by administration for item 5 (non-uniform)
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Conclusions
Differences between the performance of the electronic
and pen and paper administrations of the CAMPHOR
were minor. The results showed how the Rasch model
can be used to determine the equivalence of alternative
formats of PRO measures.
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